با برنامه Player FM !
Unpacking the Potential of HER3-Targeted Therapy in NSCLC
Manage episode 391779564 series 3256997
This second episode in a 3-part series on HER3-targeted agents in NSCLC covers current clinical trials with HER3-targeted therapy, including:
- Recent data on patritumab deruxtecan (HER3-DXd) in the HERTHENA-Lung01 trial
- The EGFRxHER3 bispecific antibodies BL-B01D1 and izalontamab
- The HER2xHER3 bispecific antibody zenocutuzumab
- The HER3-targeted antibody–drug conjugate SHR-A2009
Presenters in this series include:
Rebecca S. Heist, MD, MPH
Associate Professor of Medicine
Harvard Medical School
Medical Oncology
Massachusetts General Hospital
Boston, Massachusetts
Helena Yu, MD
Associate Attending
Department of Medicine
Memorial Sloan Kettering Cancer Center
New York, New York
Supported by an educational grant from Daiichi Sankyo, Inc.
Link to full program, including a downloadable highlights slideset:
https://bit.ly/48ecElW
170 قسمت
Manage episode 391779564 series 3256997
This second episode in a 3-part series on HER3-targeted agents in NSCLC covers current clinical trials with HER3-targeted therapy, including:
- Recent data on patritumab deruxtecan (HER3-DXd) in the HERTHENA-Lung01 trial
- The EGFRxHER3 bispecific antibodies BL-B01D1 and izalontamab
- The HER2xHER3 bispecific antibody zenocutuzumab
- The HER3-targeted antibody–drug conjugate SHR-A2009
Presenters in this series include:
Rebecca S. Heist, MD, MPH
Associate Professor of Medicine
Harvard Medical School
Medical Oncology
Massachusetts General Hospital
Boston, Massachusetts
Helena Yu, MD
Associate Attending
Department of Medicine
Memorial Sloan Kettering Cancer Center
New York, New York
Supported by an educational grant from Daiichi Sankyo, Inc.
Link to full program, including a downloadable highlights slideset:
https://bit.ly/48ecElW
170 قسمت
همه قسمت ها
×به Player FM خوش آمدید!
Player FM در سراسر وب را برای یافتن پادکست های با کیفیت اسکن می کند تا همین الان لذت ببرید. این بهترین برنامه ی پادکست است که در اندروید، آیفون و وب کار می کند. ثبت نام کنید تا اشتراک های شما در بین دستگاه های مختلف همگام سازی شود.